4
Changes in Ownership
LABCORP HOLDINGS INC. Filed Acc 0000920148-26-000151
EVP and President, Diagnostics sold 234 shares at $286.19 ($66,968)
- EVP and President, Diagnostics gave up 93 shares (to pay taxes)
- EVP and President, Diagnostics acquired 327 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Vaughn Bryan T · EVP and President, Diagnostics
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +327 | 7,072.57 | D | ||
| 2026-07-01 | Shares withheld for taxes : show line 2 in the form 10b5-1 | −93 | $283.88 | $26,401 | 6,979.57 | D |
| 2026-07-02 | Sale : show line 3 in the form 10b5-1 | −234 | $286.19 | $66,968 | 6,745.57 | D |
| Open-market sales · 234 sh · avg $286.19 · $66,968 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-01 | Exercise or conversion : show line 4 in the form 10b5-1 Restricted Stock Unit | −327 | 3,704 | D |
Loading xslF345X06/form4.xml…